SCHEMBL6014539

SCHEMBL6014539

C1=C(NCc2ccccc2)CCCC1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
EPHX1 P07099 1/20 0.46
DPP7 Q9UHL4 3/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
APEX1 P27695 1/20 0.41
HPGD P15428 3/20 0.40
ALDH1A1 P00352 1/20 0.40
GRIN2B Q13224 1/20 0.40
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FABP1 P07148 1/20 0.38
FABP6 P51161 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796493 0.98 POLB (0.54) POLBLMNAMAPTEPHX1DPP7
SCHEMBL6248215 0.94 POLB (0.57) POLBLMNAMAPTEPHX1DPP7
SCHEMBL9630573 0.88 POLB (0.53) POLBLMNAMAPTKMT2AMEN1
SCHEMBL9433553 0.82 L3MBTL1 (0.47) LMNAMAPTEPHX1DPP7KMT2A
SCHEMBL3370120 0.74 POLB (0.50) POLBLMNAMAPTDPP7KMT2A
SCHEMBL23023141 0.73 EPHX1 (0.55) MAPTEPHX1DPP7KMT2AMEN1
SCHEMBL1936330 0.72 POLB (0.49) POLBLMNAMAPTDPP7KMT2A
SCHEMBL9544841 0.71 POLB (1.00) POLBLMNAMAPTKMT2AMEN1
SCHEMBL1485578 0.71 HSD17B10 (0.44) POLBLMNAMAPTDPP7KMT2A
SCHEMBL28907427 0.70 POLB (0.48) POLBLMNAMAPTEPHX1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
CN-1136203-C Benzoxazine and benzothiazine derivatives and their use in medicine ���ֹɷݹ�˾ 2004-01-28 CN disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed
CN-1278802-A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals SCHERING AG (DE) 2001-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 POLB 2158/4885LMNA 1981/4885MAPT 2366/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 POLB 2158/4885LMNA 1981/4885MAPT 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.